Serial measurement of high-sensitivity C-reactive protein following an acute coronary syndrome may help flag patients at elevated risk for morbidity and mortality, finds a secondary analysis of the VISTA-16 trial.
New Imaging Biomarker of Coronary Inflammation Shows Prognostic Value Exceeding All Current Noninvasive Measures
A novel biomarker derived from coronary CT angiography has been found to identify residual cardiovascular risk with independent and incremental value over modern risk scores and imaging measures.